Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7,458Revenue $M6,418Net Margin (%)2.3Z-Score3.1
Enterprise Value $M9,421EPS $1.4Operating Margin %6.7F-Score7
P/E(ttm))56.9Cash Flow Per Share $3.3Pre-tax Margin (%)4.6Higher ROA y-yY
Price/Book3.010-y EBITDA Growth Rate %-0.5Quick Ratio1.2Cash flow > EarningsY
Price/Sales1.35-y EBITDA Growth Rate %3.3Current Ratio1.8Lower Leverage y-yN
Price/Cash Flow10.8y-y EBITDA Growth Rate %32.9ROA % (ttm)2.2Higher Current Ratio y-yY
Dividend Yield %1.1Insider Buy (3m)1ROE % (ttm)5.4Less Shares Outstanding y-yY
Payout Ratio %47.0Shares Outstanding M97.1ROI % (ttm)4.0Gross Margin Increase y-yN

Gurus Latest Trades with OCR

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
OCRJoel Greenblatt 2014-12-31 Sold Out -0.31%$60.42 - $73.73
($68.02)
$ 76.8011%Sold Out0
OCRJoel Greenblatt 2014-09-30 Add0.28%$61.43 - $66.49
($63.51)
$ 76.8017%Add 929.98%501,043
OCRJoel Greenblatt 2014-06-30 Add0.04%$57.54 - $66.51
($62.07)
$ 76.8019%Add 1336.68%48,646
OCRJoel Greenblatt 2014-03-31 Reduce-0.01%$56.55 - $64.54
($60.65)
$ 76.8021%Reduce -71.62%3,386
OCRJoel Greenblatt 2013-12-31 Reduce-0.14%$53.81 - $60.39
($57.24)
$ 76.8025%Reduce -86.30%11,932
OCRWallace Weitz 2013-12-31 Sold Out -0.24%$53.81 - $60.39
($57.24)
$ 76.8025%Sold Out0
OCRWallace Weitz 2013-09-30 Reduce-1.19%$47.68 - $56.28
($53.39)
$ 76.8030%Reduce -84.78%113,700
OCRJoel Greenblatt 2013-09-30 Buy 0.16%$47.68 - $56.28
($53.39)
$ 76.8030%New holding87,071
OCRJean-Marie Eveillard 2013-09-30 Reduce-0.16%$47.68 - $56.28
($53.39)
$ 76.8030%Reduce -55.65%851,300
OCRWallace Weitz 2013-06-30 Reduce-1.37%$40.82 - $47.97
($44.74)
$ 76.8042%Reduce -52.62%746,920
OCRHOTCHKIS & WILEY 2013-06-30 Sold Out -0.29%$40.82 - $47.97
($44.74)
$ 76.8042%Sold Out0
OCRJoel Greenblatt 2013-06-30 Sold Out -0.25%$40.82 - $47.97
($44.74)
$ 76.8042%Sold Out0
OCRJoel Greenblatt 2013-03-31 Buy 0.25%$36.1 - $40.72
($38.52)
$ 76.8050%New holding122,850
OCRJoel Greenblatt 2012-12-31 Sold Out -0.02%$32.98 - $36.59
($34.81)
$ 76.8055%Sold Out0
OCRJoel Greenblatt 2012-09-30 Reduce-0.1%$30.68 - $35.53
($32.29)
$ 76.8058%Reduce -80.66%10,660
OCRJoel Greenblatt 2012-06-30 Buy 0.13%$29.5 - $36.01
($33.2)
$ 76.8057%New holding55,131
OCRRay Dalio 2012-06-30 Sold Out -0.06%$29.5 - $36.01
($33.2)
$ 76.8057%Sold Out0
OCRHOTCHKIS & WILEY 2012-03-31 Add0.23%$32.51 - $35.56
($31.82)
$ 76.8059%Add 374.68%1,376,484
OCRRay Dalio 2012-03-31 Add0.05%$32.51 - $35.56
($31.82)
$ 76.8059%Add 1622.17%101,281
OCRJoel Greenblatt 2012-03-31 Sold Out -0.2%$32.51 - $35.56
($31.82)
$ 76.8059%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

OCR is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


OCR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HEYER STEVEN JDirector 2015-03-05Buy6,630$75.461.78view
Wallman AmyDirector 2015-03-02Sell1,874$77.44-0.83view
Wallman AmyDirector 2014-08-20Sell5,672$63.8420.3view
Kraft Robert O.SVP & CFO 2014-05-06Buy1,500$6028view
Sahney NitinPresident & COO 2014-04-30Buy10,000$58.4931.3view
Sahney NitinPresident & COO 2014-04-30Buy10,000$58.4931.3view
Carpenter Randall ASVP and CIO 2013-05-24Sell17,587$45.8567.5view
Stamps Jeffrey MEVP & President, LTC Ops 2012-11-05Sell40,560$35.36117.19view
Sahney NitinCOO & President, SCG 2012-08-03Buy10,000$32140view
Workman John LInterim CEO, President & CFO 2012-07-30Buy5,000$31.14146.63view

Press Releases about OCR :

    Quarterly/Annual Reports about OCR:

    News about OCR:

    Articles On GuruFocus.com
    phone Dec 19 2014 
    It's Time to Follow Chris Davis and Buy Laboratory Corp Jan 15 2014 
    Steven Romick’s Third Quarter Sells at FPA Crescent Fund Oct 17 2013 
    Waiting for Gold Rain, Wally Weitz Does "Unnaturally Well" Sep 23 2013 
    First Pacific Advisors’ Major Selling and Reductions in Second Quarter Aug 15 2013 
    Steven Romick Comments on Omnicare Jul 29 2013 
    Steven Romick on WealthTrack Oct 20 2012 
    Weekly CEO Buys Highlight: SYMC, TDY, PNK, FNFG, OCR Aug 04 2012 
    Weitz Partners Value Fund Commentary: CVS, TGT, BRK.A, BRK.B Nov 11 2011 
    Daily Dividend Report: HNZ, OCR, SEIC, FPTB, EDE, FISI May 26 2011 

    More From Other Websites
    Omnicare Announces Conversion Rate Adjustment for Convertible Notes; Series A and Series B Trust... Mar 27 2015
    Omnicare Announces Conversion Rate Adjustment for Convertible Notes; Series A and Series B Trust... Mar 27 2015
    Omnicare Announces Conversion Rate Adjustment for Convertible Notes; Series A and Series B Trust... Mar 27 2015
    [$$] High Court Gives Omnicare Another Shot at Stopping Investor Suit Mar 24 2015
    Supreme Court separates facts from opinion in Omnicare ruling Mar 24 2015
    US high court limits investor suits over deceptive comments Mar 24 2015
    US high court limits investor suits over deceptive comments Mar 24 2015
    Supreme Court Protects 'Opinions' From Suit -- Unless They're Contradicted By The Facts Mar 24 2015
    Moment of truth: Omnicare wins U.S. case over 'untrue' statements Mar 24 2015
    High court limits securities suits over deceptive comments Mar 24 2015
    High court limits securities suits over deceptive comments Mar 24 2015
    Before noon: Greece to run out of money? Mar 24 2015
    Kentucky joins lawsuit against Omnicare, claiming billions in losses Mar 17 2015
    Omnicare's Specialty Care Group Advanced Care Scripts (ACS) to Provide Specialty Pharmacy Services... Mar 05 2015
    Omnicare's Specialty Care Group Advanced Care Scripts (ACS) to Provide Specialty Pharmacy Services... Mar 05 2015
    OMNICARE INC Financials Mar 04 2015
    Omnicare (OCR) Q4 Earnings, Sales Top Estimates; Rise Y/Y - Analyst Blog Mar 02 2015
    Omnicare Specialty Care Group's ACS to Provide Specialty Pharmacy Services for Bayer's Nexavar®... Mar 02 2015
    Omnicare Specialty Care Group's ACS to Provide Specialty Pharmacy Services for Bayer's Nexavar®... Mar 02 2015
    Omnicare Specialty Care Group's ACS to Provide Specialty Pharmacy Services for Bayer's Nexavar®... Mar 02 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK